Release 4B

This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Immunization-example-protocol.xml

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Example where the provider indicates the protocol being followed (id = "protocol")

<?xml version="1.0" encoding="UTF-8"?>
<Immunization xmlns="http://hl7.org/fhir"><id value="protocol"/><text ><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p ><b >Generated Narrative</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px
 solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource &quot;protocol&quot; </p></div><p ><b >identifier</b>: id: urn:oid:1.3.6.1.4.1.21367.2005年3月7日.1234</p><p ><b >status</b>: completed</p><p ><b >vaccineCode</b>: Twinrix (HepA/HepB) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.1.0/CodeSystem-v2-0292.html">PH_VaccinesAdministeredCVX_CDC_NIP</a>#104)</span></p><p ><b >patient</b>: <a href="patient-example.html">Patient/example</a> &quot;Peter CHALMERS&quot;</p><p ><b >encounter</b>: <a href="encounter-example.html">Encounter/example</a></p><p ><b >occurrence</b>: 2018年06月18日</p><p ><b >primarySource</b>: true</p><p ><b >location</b>: <a href="location-1.html">Location/1</a> &quot;South Wing, second floor&quot;</p><p ><b >manufacturer</b>: <a href="organization-hl7.html">Organization/hl7</a> &quot;Health Level Seven International&quot;</p><p ><b >lotNumber</b>: PT123F</p><p ><b >expirationDate</b>: 2018年12月15日</p><p ><b >site</b>: left arm <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.1.0/CodeSystem-v3-ActSite.html">ActSite</a>#LA)</span></p><p ><b >route</b>: Injection, intramuscular <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.1.0/CodeSystem-v3-RouteOfAdministration.html">RouteOfAdministration</a>#IM)</span></p><p ><b >doseQuantity</b>: 5 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><blockquote ><p ><b >performer</b></p><p ><b >function</b>: Ordering Provider <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.1.0/CodeSystem-v2-0443.html">providerRole</a>#OP)</span></p><p ><b >actor</b>: <a href="practitioner-example.html">Practitioner/example</a> &quot;Adam CAREFUL&quot;</p></blockquote><blockquote ><p ><b >performer</b></p><p ><b >function</b>: Administering Provider <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.1.0/CodeSystem-v2-0443.html">providerRole</a>#AP)</span></p><p ><b >actor</b>: <a href="practitioner-example.html">Practitioner/example</a> &quot;Adam CAREFUL&quot;</p></blockquote><p ><b >isSubpotent</b>: false</p><p ><b >programEligibility</b>: Not Eligible <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="codesystem-immunization-program-eligibility.html">Immunization Event Program Eligibility</a>#ineligible)</span></p><p ><b >fundingSource</b>: Private <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="codesystem-immunization-funding-source.html">Immunization Event Funding Source</a>#private)</span></p><blockquote ><p ><b >protocolApplied</b></p><p ><b >series</b>: 2-dose</p><p ><b >targetDisease</b>: Viral hepatitis, type A <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#40468003)</span></p><p ><b >doseNumber</b>: 1</p></blockquote><blockquote ><p ><b >protocolApplied</b></p><p ><b >series</b>: 3-dose</p><p ><b >targetDisease</b>: Type B viral hepatitis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#66071002)</span></p><p ><b >doseNumber</b>: 2</p></blockquote></div></text><identifier ><system value="urn:ietf:rfc:3986"/><value value="urn:oid:1.3.6.1.4.1.21367.2005年3月7日.1234"/></identifier><status value="completed"/><vaccineCode ><coding ><system value="http://hl7.org/fhir/sid/cvx"/><code value="104"/></coding><text value="Twinrix (HepA/HepB)"/></vaccineCode><patient ><reference value="Patient/example "/></patient><encounter ><reference value="Encounter/example "/></encounter><occurrenceDateTime value="2018年06月18日"/><primarySource value="true"/><location ><reference value="Location/1 "/></location><manufacturer ><reference value="Organization/hl7 "/></manufacturer><lotNumber value="PT123F"/><expirationDate value="2018年12月15日"/><site ><coding ><system value="http://terminology.hl7.org/CodeSystem/v3-ActSite"/><code value="LA"/><display value="left arm"/></coding></site><route ><coding ><system value="http://terminology.hl7.org/CodeSystem/v3-RouteOfAdministration"/><code value="IM"/><display value="Injection, intramuscular"/></coding></route><doseQuantity ><valuevalue="5"/><systemvalue="http://unitsofmeasure.org"/><codevalue="mg"/></doseQuantity><performer ><function ><coding ><system value="http://terminology.hl7.org/CodeSystem/v2-0443"/><code value="OP"/></coding></function><actor ><reference value="Practitioner/example "/></actor></performer><performer ><function ><coding ><system value="http://terminology.hl7.org/CodeSystem/v2-0443"/><code value="AP"/></coding></function><actor ><reference value="Practitioner/example "/></actor></performer><isSubpotent value="false"/><programEligibility ><coding ><system value="http://terminology.hl7.org/CodeSystem/immunization-program-eligibility"/><code value="ineligible"/></coding></programEligibility><fundingSource ><coding ><system value="http://terminology.hl7.org/CodeSystem/immunization-funding-source"/><code value="private"/></coding></fundingSource><protocolApplied ><series value="2-dose"/><targetDisease ><coding ><system value="http://snomed.info/sct"/><code value="40468003"/></coding></targetDisease><doseNumberPositiveInt value="1"/></protocolApplied><protocolApplied ><series value="3-dose"/><targetDisease ><coding ><system value="http://snomed.info/sct"/><code value="66071002"/></coding></targetDisease><doseNumberPositiveInt value="2"/></protocolApplied></Immunization>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.

AltStyle によって変換されたページ (->オリジナル) /